Clinical Research Directory
Browse clinical research sites, groups, and studies.
Virtual Reality-Based Smoking Cessation Treatment in Patients With Schizophrenia
Sponsor: Dokuz Eylul University
Summary
Schizophrenia is associated with high rates of cigarette smoking, which contributes to serious physical health problems and reduced life expectancy. Existing smoking cessation treatments have shown limited long-term success in this population. Virtual Reality-based interventions may provide a new approach for supporting smoking cessation. This study evaluated the effects of a 10-week virtual reality-based smoking cessation program in patients with schizophrenia and healthy smokers. Participants were assigned to either a virtual reality intervention group or a no-intervention control group. Smoking behavior, nicotine dependence, clinical symptoms, cognitive functioning, and quality of life were assessed before and after the intervention period.
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
160
Start Date
2018-09-17
Completion Date
2020-01-15
Last Updated
2026-06-02
Healthy Volunteers
Yes
Conditions
Interventions
Schizophrenia VR Intervention Group
Participants received Virtual Reality-based smoking cessation treatment consisting of immersive virtual scenarios designed to reduce smoking behavior and support smoking cessation. The intervention was administered over 10 weeks through structured virtual reality sessions.
Healthy Control VR Intervention Group
Participants received Virtual Reality-based smoking cessation treatment consisting of immersive virtual scenarios designed to reduce smoking behavior and support smoking cessation. The intervention was administered over 10 weeks through structured virtual reality sessions.
Locations (1)
Dokuz Eylul University Faculty of Medicine
Izmir, Balçova, Turkey (Türkiye)